373 related articles for article (PubMed ID: 17111267)
1. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
[TBL] [Abstract][Full Text] [Related]
3. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
5. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
6. Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
Li S; Xu B; Fan S; Kang B; Deng L; Chen D; Yang B; Tang F; He Z; Xue Y; Zhou JC
Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1107-1117. PubMed ID: 36065506
[TBL] [Abstract][Full Text] [Related]
7. Association between Polymorphisms of
Chang HH; Hsueh YS; Cheng YW; Ou HT; Wu MH
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959948
[TBL] [Abstract][Full Text] [Related]
8. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
König J; Zolk O; Singer K; Hoffmann C; Fromm MF
Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
[TBL] [Abstract][Full Text] [Related]
9. OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects.
Moreno-Navarrete JM; Ortega FJ; Rodríguez-Hermosa JI; Sabater M; Pardo G; Ricart W; Fernández-Real JM
Diabetes; 2011 Jan; 60(1):168-76. PubMed ID: 20956498
[TBL] [Abstract][Full Text] [Related]
10. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
[TBL] [Abstract][Full Text] [Related]
11. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.
Tzvetkov MV; Vormfelde SV; Balen D; Meineke I; Schmidt T; Sehrt D; Sabolić I; Koepsell H; Brockmöller J
Clin Pharmacol Ther; 2009 Sep; 86(3):299-306. PubMed ID: 19536068
[TBL] [Abstract][Full Text] [Related]
12. Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients.
Jung N; Lehmann C; Rubbert A; Schömig E; Fätkenheuer G; Hartmann P; Taubert D
Infection; 2013 Apr; 41(2):379-85. PubMed ID: 22875535
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol.
Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO
Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690
[TBL] [Abstract][Full Text] [Related]
14. The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin.
Kashi Z; Masoumi P; Mahrooz A; Hashemi-Soteh MB; Bahar A; Alizadeh A
Diabetes Res Clin Pract; 2015 Apr; 108(1):78-83. PubMed ID: 25662675
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
16. Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes.
Kawoosa F; Shah ZA; Masoodi SR; Amin A; Rasool R; Fazili KM; Dar AH; Lone A; Ul Bashir S
BMC Endocr Disord; 2022 May; 22(1):140. PubMed ID: 35619086
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in human organic cation transporters and metformin action.
Takane H; Shikata E; Otsubo K; Higuchi S; Ieiri I
Pharmacogenomics; 2008 Apr; 9(4):415-22. PubMed ID: 18384255
[TBL] [Abstract][Full Text] [Related]
18. Disposition of metformin: variability due to polymorphisms of organic cation transporters.
Zolk O
Ann Med; 2012 Mar; 44(2):119-29. PubMed ID: 21366511
[TBL] [Abstract][Full Text] [Related]
19. Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters.
Meyer MJ; Falk S; Römer S; Prinzinger C; Tacke S; Geyer J; Simm S; Tzvetkov MV
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563491
[TBL] [Abstract][Full Text] [Related]
20. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
